Charles Oh

Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active- and placebo-controlled study

Craig T. Hartrick, Ilse Van Hove, Jens‐Ulrich Stegmann et al. · Clinical Therapeutics · 2009 · 179 citations

Phase Iii, Osteoarthritis, Orthopaedics +7

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain

Stephen Daniels, Ed Casson, Jens‐Ulrich Stegmann et al. · Current Medical Research and Opinion · 2009 · 131 citations

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial

Peter A. LeWitt, Robert A. Hauser, Rajesh Pahwa et al. · The Lancet Neurology · 2019 · 114 citations

Placebo-controlled Phase 3, Parkinson Disease, Motor Disorder +5

Results of Caldwell‐Luc After Failed Endoscopic Middle Meatus Antrostomy in Patients With Chronic Sinusitis

Jeffrey L. Cutler, James A. Duncavage, Keith E. Matheny et al. · The Laryngoscope · 2003 · 53 citations

Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease

Robert A. Hauser, Stuart Isaacson, Aaron Ellenbogen et al. · Parkinsonism & Related Disorders · 2019 · 45 citations · Full text